1. Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model

   • Bruce E. Hillner
   • Thomas J. Smith
   • Christopher E. Desch

   Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 97 - 105

2. Breast cancer surveillance — a cost-effective strategy

   • David V. Schapira

   Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 107 - 111

3. Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature

   • Martin L. Brown
   • Lou Fintor

   Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 113 - 118

4. Payment and coverage issues affecting medical oncology

   • Joseph S. Bailes

   Cost analysis of diagnosis and treatment in breast cancer — Mini-symposium Pages: 119 - 126

5. Predicting recurrence in axillary-node negative breast cancer patients

   • Dutzu Rosner
   • Warren W. Lane

   Report Pages: 127 - 139

6. Human recombinant interferon-β_SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse

   • David F. C. Gibson
   • Delinda A. Johnson
   • V. Craig Jordan

   Report Pages: 141 - 150

7. Mechanisms involved in the metastasis of cancer to bone

   • F. William Orr
   • Paul Kostenuik
   • Gurmit Singh

   Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 151 - 163

8. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma

   • S. D. Pencil
   • Y. Toh
   • G. L. Nicolson

   Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 165 - 174

9. Nm23 and breast cancer metastasis

   • Patricia S. Steeg
   • Abel De La Rosa
   • Alvaro Leone

   Breast Cancer Metastases — from Genome to Therapy (Mini-symposium) Pages: 175 - 187

10. 16th annual San Antonio breast cancer symposium November 5-6, 1993

    Announcement Pages: 189 - 189